STE · 10-Q · 2026Q2 · Full report

Manufacturing Capacity Expansion

STERIS plc · 2026-08-07 · Importance 37 · Surprise 42

On August 5, 2026, STERIS announced a targeted restructuring plan to consolidate formulated-chemistry manufacturing and distribution at a new Center of Excellence in North Carolina. The plan anticipates closing chemistry manufacturing and distribution facilities in St. Louis, Missouri, and Plymouth, Minnesota, while expanding capacity and optimizing the U.S. network. STERIS expects approximately $55 million to $70 million of pre-tax restructuring charges, including $40 million to $50 million of cash expenditures and $15 million to $20 million of non-cash charges, incurred over time through anticipated completion in fiscal 2030. The initiative covers Healthcare and Life Sciences formulated-chemistries businesses that together generate more than $700 million in annual revenue.

Key facts

• Purchases of property, plant, equipment, and intangibles (capital expenditures) for the three months ended June 30, 2026: $87.5 million, compared to $93.6 million for the three months ended June 30, 2025. source